Abstract

PSMA-PET imaging is becoming increasingly prevalent in prostate cancer. Also, whether indications and acquisition protocols are well-known, interpretation is, for now, more challenging, and a tool like PSMA-RADS score may homogenize practices. Nevertheless, its impact on patients’ management already makes it an indispensable imaging.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.